SynBioBeta Speaker
Maria Fátima Lucas
Zymvol
CEO & Founder
With a PhD in Computational Chemistry and more than 20 years of experience in protein science, Maria Fátima Lucas is the CEO and founder of Zymvol, an innovative biotechnology company developing biocatalysis through its unique hyperrealistic computer simulations. By combining physics-based simulations, AI, and real-world industrial data, Zymvol designs scale-ready enzymes faster, cheaper, and with higher predictability than traditional approaches. Since its founding in 2017, the company has worked on more than 150 projects with clients worldwide, and has been an active contributor to the scientific research landscape. Thanks to this work, in 2020 Maria Fátima Lucas was one of the winners of the EU Women Innovators Award, granted by the European Commission.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Maria Fátima
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
